UK markets closed

IDEAYA Biosciences, Inc. (IDYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.18+0.69 (+1.66%)
At close: 04:00PM EDT
42.18 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
157,018
68,632
92,046
72,037
Other short-term investments
368,096
296,197
154,724
211,548
Total cash
525,114
364,829
246,770
283,585
Net receivables
18
211
1,103
1,877
Other current assets
7,500
5,414
3,123
3,143
Total current assets
532,632
370,454
250,996
288,605
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
18,021
16,546
14,258
13,370
Accumulated depreciation
-9,611
-7,553
-5,597
-3,894
Net property, plant and equipment
8,410
8,993
8,661
9,476
Equity and other investments
107,492
8,317
121,293
0
Other long-term assets
782
205
397
188
Total non-current assets
116,684
17,515
130,351
9,664
Total assets
649,316
387,969
381,347
298,269
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
6,598
4,280
2,100
953
Accrued liabilities
18,756
16,999
12,320
8,516
Deferred revenues
0
8,568
29,040
27,613
Other current liabilities
-
-
-
18
Total current liabilities
27,101
31,718
45,159
38,640
Non-current liabilities
Deferred revenues
0
5,185
31,192
56,160
Other long-term liabilities
-
-
-
12
Total non-current liabilities
1,125
6,796
34,674
61,355
Total liabilities
28,226
38,514
79,833
99,995
Stockholders' equity
Common stock
7
5
4
3
Retained earnings
-348,364
-235,403
-176,748
-126,986
Accumulated other comprehensive income
562
-2,871
-712
7
Total stockholders' equity
621,090
349,455
301,514
198,274
Total liabilities and stockholders' equity
649,316
387,969
381,347
298,269